Elsevier

Atherosclerosis

Volume 153, Issue 1, November 2000, Pages 59-67
Atherosclerosis

Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters

https://doi.org/10.1016/S0021-9150(00)00396-8Get rights and content

Abstract

Administration of ursodeoxycholic acid (UDCA) has been shown to decrease serum total and low density lipoprotein (LDL) cholesterol in hypercholesterolemic patients with primary biliary cirrhosis. Results of previous studies prompted us to postulate that the cholesterol-lowering effect of UDCA may be due, at least in part, to a direct increment in hepatic LDL receptor binding [Bouscarel et al., Biochem J, 1991;280:589; Bouscarel et al., Lipids 1995;30:607]. The aim of the present investigation was to determine the ability of UDCA to enhance hepatocellular LDL receptor recruitment, as determined by its effect in vivo on LDL uptake, and its effect in vitro on LDL binding, under conditions of moderately elevated serum cholesterol. Study groups consisted of male golden Syrian hamsters fed either a standard chow diet (control), a 0.15% cholesterol-containing diet, or a 0.15% cholesterol-containing diet supplemented with either 0.1% UDCA, or 0.1% chenodeoxycholic acid (CDCA). Cholesterol feeding increased (P<0.01) total serum cholesterol by 44%, and was associated with a 10-fold accumulation of cholesteryl esters in the liver (P<0.01). In vivo, hepatic uptake of [U-14C]sucrose-labeled hamster LDL was increased (P<0.05) to a level of 454±101 μl in animals fed a cholesterol-containing diet supplemented with UDCA, compared to that either without UDCA (337±56 μl), or with CDCA (240±49 μl). The hepatic uptake of [U-14C]sucrose-labeled methylated human LDL, a marker of LDL receptor-independent LDL uptake, was unaffected by bile acid feeding. In vitro, specific binding of [125I]hamster LDL to isolated hepatocytes was determined at 4°C, in presence and absence of 700 μmol/l UDCA. The KD ranged from 25 to 31 μg/ml, and was not affected by either cholesterol feeding or UDCA. In the presence of UDCA, the Bmax was increased by 19% (P<0.05) in cells isolated from control animals and by 29% (P<0.01) in cells isolated from hamsters fed a cholesterol-supplemented diet. In conclusion, in dietary hypercholesterolemic hamsters, both chronic in-vivo and acute in-vitro treatments with UDCA resulted in restoration of hepatic LDL binding and uptake to levels observed in control hamsters.

Introduction

The low density lipoprotein (LDL) receptor plays a central role in the regulation of cholesterol homeostasis, while the liver is a key organ in the maintenance of whole body cholesterol balance [1], [2]. In a number of species, including the hamster, most of receptor-mediated clearance of LDL occurs in the liver [3], [4], [5] by rapid internalization of the complex formed by the binding of the apolipoprotein-B100-containing particle to the LDL receptor [6]. Once in the cell, the LDL particle dissociates, and the receptor generally is cycled back to the cell surface membrane [7].

The activity of the LDL receptor is tightly regulated by changes in cholesterol supply and demand. Hepatic LDL receptor synthesis and cycling can be markedly suppressed by dietary cholesterol [8], [9]. Conversely, administration of both bile acid binding resins, which augment hepatocellular bile acid synthesis, and cholesterol synthesis inhibitors, increase the number of LDL receptors, by increasing the cellular cholesterol demand [10], [11]. The consequent changes in cellular cholesterol pools modulate the production of LDL receptor mRNA and the synthesis of the LDL receptor.

It has previously been shown in vivo, in the golden Syrian hamster, that chronic feeding of ursodeoxycholic acid (UDCA), in contrast to that of its 7α-hydroxyl epimer, chenodeoxycholic acid (CDCA), evoked a significant increment in hepatic LDL uptake. However, this occurred in spite of both a 55–71% enrichment of the bile acid pool with CDCA and a marked suppression of bile acid synthesis [12]. This increased LDL receptor-dependent LDL uptake and degradation in vitro have also been documented, upon acute exposure to UDCA, in hepatocytes isolated from standard rodent chow-fed hamsters [13], [14]. Furthermore, recent studies from our laboratory have demonstrated that UDCA interacts directly with the LDL receptor, in the absence of any effects on either the LDL particle or on the membrane lipid composition, and independently of any effects on LDL receptor synthesis or cycling [13], [15]. Thus, the ability of UDCA to directly augment LDL receptor-dependent LDL uptake is independent of changes in cellular cholesterol pools.

Administration of UDCA has been shown to decrease serum total and LDL cholesterol in hypercholesterolemic patients with primary biliary cirrhosis [16]. In light of results of previous studies, it was postulated that the cholesterol-lowering effect of UDCA may be due, in part, to a direct increment in LDL receptor binding [13], [15]. The present investigation was undertaken in order to determine the ability of UDCA to enhance hepatocellular LDL receptor recruitment, as determined by its effect both in vivo on LDL uptake, and in vitro on LDL binding, under conditions of moderately elevated serum cholesterol concentrations [17]. This was achieved by feeding male golden Syrian hamsters an excess of cholesterol in order to induce mild hypercholesterolemia. Under these conditions, the effects of UDCA on parameters of hepatic LDL metabolism were studied both in vivo and in vitro.

Section snippets

Materials

Sodium 125I (specific activity 16–20 mCi/μg) and [U-14C]sucrose (specific activity 380 μCi/μmol) were purchased from Amersham Corporation (Arlington Heights, IL). Gelatin and bovine serum albumin (fraction V) were purchased from Sigma (St. Louis, MO). UDCA was supplied by Tokyo Tanabe (Tokyo, Japan), and CDCA by Dr Falk GmbH (Freiburg, Germany). Both UDCA and CDCA were 98–99% pure, as judged by gas–liquid chromatography. All other chemicals used were of analytical grade available from

Serum lipid concentrations

After 3 weeks of feeding a 0.15% cholesterol-supplemented diet, total serum cholesterol concentrations increased by 44%, (Table 1). The percentage of serum cholesterol associated to HDL particles was significantly decreased from 48 to 44% of the total serum cholesterol in the hypercholesterolemic animals.

In those hamsters fed a 0.15% cholesterol-supplemented diet, CDCA supplementation induced a significant decrease in the percentage of serum HDL cholesterol, and a consequent increase in the

Discussion

Results of the present study in dietary hypercholesterolemic hamsters indicate that both chronic, in-vivo and acute, in-vitro treatments with UDCA were able to restore the respective hepatic LDL binding and uptake to the levels observed in normocholesterolemic hamsters. Furthermore, the administration of UDCA in conjunction with a high cholesterol diet suppressed the biotransformation of UDCA to CDCA. This possibly removed some of the repressive effects of CDCA on hepatic LDL uptake, namely, an

Acknowledgments

The authors dedicate this work to Mauro Malavolti. His friendship and collaboration will be greatly missed. The authors are grateful to Joan Fasulo for assistance in the studies of hepatocellular lipid determinations. The studies were supported, in part, by grants from the American Heart Association Nation's Capital Affiliate, Inc. (B.B.), and the General Medical Research Service of the Veterans Administration (S.J.R.). B.B. is supported, in part, by NIH/NIDDK DK-46954. These studies were

References (47)

  • D. Gurantz et al.

    Enzymatic measurement of choline-containing phospholipids in bile

    J. Lipid Res.

    (1981)
  • H. Fromm et al.

    Use of a simple enzymatic assay for cholesterol analysis in human bile

    J. Lipid Res.

    (1980)
  • M. Malavolti et al.

    Cerebral low-density lipoprotein (LDL) uptake is stimulated by acute bile drainage

    Biochim. Biophys. Acta

    (1991)
  • M.M. Bradford

    A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

    Anal. Biochem.

    (1976)
  • H. Fromm et al.

    Sensitivity and specificity in tests of distal ileal function: prospective comparison of bile acid and vitamin B 12 absorption in ileal resection patients

    Gastroenterology

    (1973)
  • D.W. Bilheimer et al.

    The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations

    Biochim. Biophys. Acta

    (1972)
  • D.M. Heuman et al.

    Regulation of bile acid synthesis. III. Correlation between biliary bile salt hydrophobicity index and the activities of enzymes regulating cholesterol and bile acid synthesis in the rat

    J. Lipid Res.

    (1989)
  • H. Ohtani et al.

    Effects of dietary cholesterol and fatty acids on plasma cholesterol level and hepatic lipoprotein metabolism

    J. Lipid Res.

    (1990)
  • B. Jackson et al.

    The effects of feeding a saturated fat-rich diet on enzymes of cholesterol metabolism in the liver, intestine and aorta of the hamster

    Biochim. Biophys. Acta

    (1990)
  • V.A. Sessions et al.

    Low density lipoprotein binding to monolayer cultures of hepatocytes isolated from hamsters fed different dietary fatty acids

    Biochim. Biophys. Acta

    (1995)
  • J.D. Horton et al.

    Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster

    J. Biol. Chem.

    (1995)
  • G. Jurgens et al.

    Modification of human serum low density lipoprotein by oxidation — characterization and pathophysiological implications

    Chem. Phys. Lipids

    (1987)
  • B.J. van de Heijning et al.

    Bile salt-induced cholesterol crystal formation from model bile vesicles: a time course study

    J. Lipid Res.

    (1994)
  • View full text